Corvus immunotherapy yields positive results in Covid-19 trial,

Corvus Pharmaceuticals has reported positive findings from an ongoing Phase I clinical trial of its immunotherapy candidate, CPI-006, in patients …, Corvus Pharmaceuticals has reported positive findings from an ongoing Phase I clinical trial of its immunotherapy candidate, CPI-006, in patients …, Read More